Company intelligence / Profile preview

Health Discovery Labs

Austin, Texas, United Stateslinkedin.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Health Discovery Labs develops MyokinE, an Electrical Muscle Stimulation system designed to provide non-volitional exercise for critically ill or unconscious patients at risk of developing ICU Acquired Weakness. The technology aims to reduce ICU stays and healthcare costs by preventing muscle atrophy in mechanically ventilated patients. The company holds a granted patent on its EMS technology.

Therapeutic areas: Neurology
Modalities: Device (Electrical Muscle Stimulation system)Electrotherapeutic apparatus
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

MyokinE

Pre-clinical

Indications: ICU-acquired weakness

Partnerships

Austin Technology Incubator

Beyond the preview

Go deeper on Health Discovery Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Health Discovery Labs.

Explore the full profile